What You Should Know:
- PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide Asset Management with participation from Labcorp, Quest Diagnostics, GenHenn Capital Venture, and existing investors. This brings the company's total funding to date to $31.5M.
- The new funding will enable PreciseDx to accelerate its growth and expand its operations. The company plans to invest in talent
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Piramidal Secures $6M to Expand Foundational AI Brain Model for Neurologists
What You Should Know:
- Upstart technology innovator Piramidal has secured $6 million in seed funding to aid its development of a barrier-breaking artificial intelligence (AI) model that will help neurologists assess brainwave data, with the potential to democratize analysis and shorten patient waiting time.
- The seed funding round attracted high-profile investors, including Y Combinator, Adverb Ventures, Lionheart Ventures, and angel investors such as founders of Intercom, Plangrid,
Read More
Ciba Health Unveils AI-Powered Disease Prevention Platform
What You Should Know:
- Ciba Health, a digital health company transforming healthcare with root-cause medicine and leveraging cutting-edge technology AI/ML, announced today its launch of Thrive by Ciba (Thrive), a data-powered, customizable disease prevention platform to help people live longer and healthier lives.
- Thrive offers deeply-personalized, comprehensive blood work, offering 100+ labs along with on-demand education to help members better understand their health and
Read More
GrayMatters Expands Footprint for Non-Invasive PTSD Treatment
What You Should Know:
- GrayMatters Health (GMH), developer of non-invasive treatments based on proprietary brain biomarkers associated with mental health disorders, today announced it is expanding its U.S. footprint with additional clinics now offering Prism for PTSD™ to patients.
- Prism for PTSD is the first prescribed self-neuromodulation device, cleared by the FDA to treat post-traumatic stress disorder (PTSD) as an adjunct to standard-of-care therapies.
Expansion of Prism
Read More
The Role of AI in Streamlining Drug Discovery and Clinical Trials: A New Era in Pharmaceutical Innovation
In the rapidly evolving world of pharmaceuticals, artificial intelligence (AI) is emerging as a game-changer. From accelerating drug discovery to enhancing the efficiency of clinical trials, AI is revolutionizing how new medicines are brought to market. This transformation is not just limited to the research and development phases; AI is also playing a critical role in ensuring that drugs meet regulatory standards.
The AI Revolution in Drug Discovery
Drug discovery has traditionally been a
Read More
Google’s AI Model Listens to Your Cough to Detect Disease
What You Should Know:
- Google Research has unveiled a groundbreaking advancement in healthcare technology with the introduction of HeAR, a bioacoustic foundation model designed to analyze human sounds and identify potential health issues.
- By leveraging the power of AI and vast amounts of audio data, HeAR aims to revolutionize disease screening, diagnosis, and monitoring.
Google’s AI Model & Dataset
The model has been trained on a massive dataset of 300 million
Read More
Clarium Secures $10.5M for AI-Powered Hospital Supply Chain
What You Should Know:
- Clarium, Inc., a healthcare technology innovator focused on transforming hospital supply chain operations, has secured a $10.5M in strategic financing round led by General Catalyst, with participation from Kaiser Permanente Ventures, Texas Medical Center Venture Fund, Yale New Haven Health, and existing investors.
- With this new funding, Clarium plans to expand its team, deepen partnerships with leading health systems, and continue refining its
Read More
BayCare to Deploy Cadence’s Remote Patient Monitoring for Chronic Disease Management
What You Should Know:
- BayCare, a healthcare system, has announced a strategic partnership with Cadence, a chronic disease management company, to implement a comprehensive remote patient monitoring and virtual care program.
- This collaboration aims to enhance the care of seniors with chronic conditions such as hypertension, congestive heart failure, and type 2 diabetes across Florida’s Tampa Bay and West Central regions.
Proactive and Preventive Healthcare to Seniors with
Read More
Reliant AI Emerges from Stealth with $11.3M for GenAI Biopharma Data Analysis
What You Should Know:
- Reliant AI, a provider of generative AI-powered data analytics software, today announced its official launch and a significant $11.3M in seed funding round led by Tola Capital and Inovia Capital, with participation from angel investor Mike Volpi, the investment will fuel the company's growth and expansion.
- Founded by a team of leading experts in natural language processing and reinforcement learning with backgrounds at DeepMind, Google Brain, and EY
Read More
West Tennessee Healthcare Expands AI Engagement with Xsolis
What You Should Know:
- Xsolis, the AI-driven health technology company fostering collaboration between healthcare providers and payers, today announced an expansion of its partnership with West Tennessee Healthcare, a healthcare system with seven hospitals serving West Tennessee, to streamline medical necessity case reviews and reduce length of stay.
- The collaboration between Xsolis and West Tennessee Healthcare has led West Tennessee Healthcare to $5.1 million in savings since the
Read More
